Table_1.xls (17.5 kB)
Results of bivariate analysis to determine the significant relative odds of having anti-RVFV seropositivity according to demographic data, clinical signs, symptoms, and exposure factors.
dataset
posted on 2015-03-12, 03:27 authored by A. Desirée LaBeaud, Sarah Pfeil, Samuel Muiruri, Saidi Dahir, Laura J. Sutherland, Zachary Traylor, Ginny Gildengorin, Eric M. Muchiri, John Morrill, C. J. Peters, Amy G. Hise, James W Kazura, Charles H. King† As determined by bivariate Χ2 testing
*Poor visual acuity defined functionally at >6/9 meters using a Snellen eye chart
^ “Recent” defined as symptoms reported in the last 30 days
< “History of” defined as symptom reported at any time
** N = number of participants with data collected in survey
Results of bivariate analysis to determine the significant relative odds of having anti-RVFV seropositivity according to demographic data, clinical signs, symptoms, and exposure factors.
